Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1881633212
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7500 N Dreamy Draw Dr, Suite 133
Phoenix, AZ, 85020
Phone (602) 277-2228
Groups this clinician bills Medicare through
Medicare paid, 2023
$33K
433 services
Medicare patients, 2023
128
Average age 75
Drug cost, 2024
$2.1M
2,590 prescriptions
Company payments, 2025
$547K
From 21 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Maria C Ospina was code 99214 (office e&m - established), 333 times for 111 patients. In total Maria C Ospina billed 433 services in 8 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 333 | 111 | $79.96 | $27K |
| 99205 Office E&M - New | Office | 32 | 32 | $139.53 | $4,465 |
| 95970 Electrical Nerve Conductivity | Office | 22 | 15 | $13.90 | $306 |
| 95983 Electrical Nerve Conductivity | Office | 17 | 11 | $38.19 | $649 |
By year: 2022 $42K for 526 services; 2023 $33K for 433 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria C Ospina prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 359 prescriptions and refills. In total Maria C Ospina wrote 2,590 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 359 | 934 | 113 | $30K |
| Rytary Carbidopa/Levodopa | 279 | 488 | 56 | $451K |
| Clonazepam Generic | 199 | 235 | 32 | $1,859 |
| Rasagiline Mesylate Generic | 152 | 376 | 38 | $32K |
| Quetiapine Fumarate Generic | 109 | 209 | 23 | $3,620 |
| Memantine Hcl Generic | 109 | 211 | 28 | $3,443 |
| Gocovri Amantadine Hcl | 95 | 99 | 13 | $287K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 90 | 196 | 25 | $2,376 |
| Amantadine Amantadine Hcl | 78 | 201 | 28 | $6,842 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 76 | 192 | 24 | $7,505 |
| Ongentys Opicapone | 70 | 130 | 16 | $84K |
| Nuplazid Pimavanserin Tartrate | 57 | 77 | Under 11 | $377K |
| Inbrija Levodopa | 52 | 56 | 11 | $168K |
| Sertraline Hcl Generic | 51 | 100 | Under 11 | $697 |
| Neupro Rotigotine | 50 | 75 | 11 | $62K |
Brand drugs: 816 claims; generic drugs: 1,774 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria C Ospina $547K ($547K in general payments such as food, travel and fees) from 21 companies. The largest payer was MDD US Operations, LLC with $171K.
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 149 | $171K |
| Neurocrine BioSciences, Inc. NBIX | 142 | $166K |
| Amneal Pharmaceuticals LLC AMRX | 72 | $87K |
| Abbvie Inc. ABBV | 95 | $47K |
| Merz Pharmaceuticals, LLC | 35 | $37K |
| Teva Pharmaceuticals USA, Inc. TEVA | 25 | $33K |
| Abbott Laboratories ABT | 14 | $2,517 |
| Medtronic, Inc. MDT | 20 | $1,330 |
| Boston Scientific Corporation BSX | 6 | $1,063 |
| ACADIA Pharmaceuticals Inc ACAD | 16 | $311 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.